Back
  1. Home
  3. Detailled Reference
Request a copy
Paper published in a journal (Scientific congresses and symposiums)
Abaloparatide-SC for postmenopausal osteoporosis: analysis of the number needed to treat compared with teriparatide.
Reginster, Jean-Yves; Black, D.M.; Hattersley, G. et al.
2017 • In Osteoporosis International, 28 Suppl 1, p. 62-63
Peer Reviewed verified by ORBi
Permalink
https://hdl.handle.net/2268/213072
 

Files (1)Send toDetailsStatisticsBibliographySimilar publications

Files

Full Text
Abaloparatide-SC for postmenopausal osteoporosis. analysis of the number needed to treat compared with teriparatide..pdf
Publisher postprint (1.18 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Details


Disciplines :
General & internal medicine
Author, co-author :
Reginster, Jean-Yves  ;  Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Black, D.M.
Hattersley, G.
Williams, G.
Hu, M.
Fitzpatrick, L.A.
Lewiecki, E.M.
Language :
English
Title :
Abaloparatide-SC for postmenopausal osteoporosis: analysis of the number needed to treat compared with teriparatide.
Publication date :
March 2017
Event name :
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Event organizer :
WCO-IOF-ESCEO
Event place :
Florence, Italy
Event date :
du 23 au 26 mars 2017
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
28 Suppl 1
Pages :
62-63
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 19 July 2017

Statistics

Number of views
180 (2 by ULiège)
Number of downloads
4 (0 by ULiège)
More statistics

Bibliography

Similar publications


Contact ORBi